Search

Nanami Kubota (University of Pittsburgh) and colleagues published a new preprint on filamentous phage exploitation of bacteria, showing that mutant Pf phages can drive P. aeruginosa populations to lower fitness through superinfection and mi

We are seeking a highly motivated Postdoc candidate to join the Phage Lab in Frankfurt, Germany, for a joint research proposal. Applicants should have a Ph.D. or equivalent, or be close to completion, with a strong publication record, excel

Eligo Bioscience in Paris is hiring a Senior In Vivo Scientist - Microbiologist, to study host-microbiome interactions and support preclinical development of microbiome therapeutics using in vivo, ex vivo, and in vitro models.

[PhD Position: Phage Pharmacokinetics] at UiT The Arctic University of Tromsø, Vascular Biology Research Group, Tromsø, Norway. This PhD project aims to explore the pharmacokinetics and biodistribution of phages using clinically relevant mo

"I was so biased. I knew too much and that's why we couldn't see the obvious answer that was right in front of us for years." In this episode of the Podovirus Podcast, we explore the intersection of AI and phage biology with Professors José

A review of recent advances in using bacteriophages to treat the most common bacterial infectious diseases of cultured fish, shellfish and crustaceans. It concludes that the documented research supports phage therapy in aquaculture but that

New format alert! Here's 5 rapidfire, off-the-cuff tips from the lab — from how to tweak plaque size to purifying filamentous phages to preventing phage cross-contamination. These first 5 are written by Jessica but we hope to crowdsource th

Evergreen 2025 is happening, and for the first time in its 50-year history, we're taking it on the road! Register for the 26th Biennial Evergreen International Phage Meeting, which will be held August 3-8, 2025, at the University of Tennes

Dear Phage Protein enthusiast, We are pleased to invite you to The Phage Protein Meeting, September 10-11, 2025 in Ghent, Belgium. The Phage Protein Meeting is an interdisciplinary conference organized by academics and dedicated to advanc

Huge milestone alert! BiomX has announced successful Phase II clinical trial results for their BX211 phage product against diabetic foot osteomyelitis! Subscribe to the Podovirus podcast to learn more — we'll be interviewing BiomX CEO Jona

Marian Dominguez-Mirazo (Georgia Institute of Technology) and colleagues published a new preprint on inferring phage trait heterogeneity from population data, showing latent period variation in cyanophages exceeds that of coliphages and bur

Jason Wilson (University of Sheffield) and colleagues published a new paper on structural analysis of a phage that penetrates bacterial S-layers, showing the phage has an unusually long tail that contracts less than other phages, likely ena

Isabella Romano (University of New Mexico) and colleagues published a new paper on RNA phage-derived vaccines against heroin and fentanyl, showing the vaccines elicit high-titer antibodies and protect against opioid-induced effects in mice

José Penadés (Imperial College London) and colleagues published a new review on phage satellite genetics, ecology and evolution, diving into how these elements impact bacterial evolution and virulence.

ERC funded doctoral/Ph.D position at LMU Munich, Carolin Wendling lab in Munich, Germany Tasks: eco-evo drivers of prophage distribution in gut bacteria/pathogens: high-throughput bioinformatics, RNA-seq, microbiology; Deadline: April 15th

ERC funded Postdoc at LMU Munich, Carolin Wendling lab in Munich, Germany Tasks: Develop a novel form of phage therapy; perform prophage-engineering (cloning); Deadline: 15 April 2025.

ERC funded doctoral/Ph.D position at LMU Munich, Carolin Wendling lab in Munich, Germany Tasks: Develop a novel form of phage therapy; perform in-vitro & in vivo infection experiments; Deadline: 15 April 2025 Required: Excellent previous

This review surveys lytic bacteriophages and related approaches being studied against antibiotic-resistant Klebsiella pneumoniae. Bacteriophage therapy: a possible alternative therapy against antibiotic-resistant strains of Klebsiella pneum

BiomX announced positive topline safety and efficacy results from its Phase 2 DANCE trial of the BX211 phage treatment for diabetic foot osteomyelitis associated with Staphylococcus aureus. BX211 was safe and well tolerated and produced a s

Bacteriophages of the Chimalliviridae family are shown to use two successive compartments during infection: a membrane-bound early phage infection (EPI) vesicle that encloses the injected genome and expresses early genes, and the protein-la